SCHEMBL29133715

SCHEMBL29133715

CS(=O)(=O)N(c1cncc(-c2ccc3ncnc(NCCc4ccccc4)c3c2)c1)S(C)(=O)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.59
PIK3CA P42336 2/20 0.59
CYP1A2 P05177 10/20 0.50
CYP3A4 P08684 10/20 0.50
MAPK1 P28482 8/20 0.50
HSD17B10 Q99714 8/20 0.50
ALDH1A1 P00352 8/20 0.50
CLK4 Q9HAZ1 8/20 0.50
CYP2D6 P10635 7/20 0.50
CYP2C19 P33261 7/20 0.50
LMNA P02545 7/20 0.50
HIF1A Q16665 6/20 0.50
USP2 O75604 6/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
KDM4E B2RXH2 4/20 0.50
HPGD P15428 4/20 0.50
TSHR P16473 4/20 0.50
MAPT P10636 3/20 0.50
TDP1 Q9NUW8 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133765 0.84 EGFR (0.54) EGFRPIK3CACYP1A2CYP3A4MAPK1
SCHEMBL29133708 0.84 EGFR (0.82) EGFRPIK3CACYP1A2CYP3A4MAPK1
SCHEMBL29775132 0.80 EGFR (0.62) EGFRPIK3CACYP1A2CYP3A4CLK4
SCHEMBL24576822 0.80 EGFR (0.62) EGFRPIK3CACYP1A2CYP3A4CLK4
SCHEMBL29133772 0.80 CYP1A2 (0.57) EGFRPIK3CACYP1A2CYP3A4MAPK1
SCHEMBL29133751 0.79 EGFR (0.68) EGFRPIK3CACYP1A2CYP3A4MAPK1
SCHEMBL29133707 0.79 IRAK4 (0.56) EGFRPIK3CACYP1A2CYP3A4MAPK1
SCHEMBL29133756 0.78 MAPK1 (0.53) EGFRPIK3CACYP1A2CYP3A4MAPK1
SCHEMBL27170398 0.78 EGFR (0.84) EGFRPIK3CACYP1A2CYP3A4MAPK1
SCHEMBL29133777 0.76 PIK3CA (0.75) EGFRPIK3CACYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 CN disclosed